Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Boguniewicz

Showing results (41-50 of 160) with videos related to

Pageof 16
Sort By:
The Journal of Investigative Dermatology|August 12, 2004
Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatologyMary M Prendergast, William Abramovits, Mark Boguniewicz, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 2, 2026
Atopic dermatitis Yardstick: a new era of topical and systemic treatmentsAnna De Benedetto, Mark Boguniewicz, Luz Fonacier, et al.
The Journal of Allergy and Clinical Immunology|August 23, 2024
Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitisLisa A Beck, Antonella Muraro, Mark Boguniewicz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 9, 2024
Atopic Dermatitis (Eczema) Guidelines 2023: HighlightsAnna De Benedetto, Mark Boguniewicz, Peck Y Ong, et al.
The Journal of Clinical Investigation|March 3, 2004
New insights into atopic dermatitisDonald Y M Leung, Mark Boguniewicz, Michael D Howell, et al.
The Journal of Allergy and Clinical Immunology|June 10, 2008
Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3Kevin O Kisich, Charles W Carspecken, Stephanie Fiéve, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 24, 2017
Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscapeMark Boguniewicz, Luz Fonacier, Emma Guttman-Yassky, et al.
The Journal of Allergy and Clinical Immunology|December 6, 2003
Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysisIchiro Nomura, Bifeng Gao, Mark Boguniewicz, et al.
Pediatric Dermatology|June 26, 2008
Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitisRichard G B Langley, Lawrence F Eichenfield, Anne W Lucky, et al.
Archives of Dermatology|October 22, 2003
1% pimecrolimus cream for atopic dermatitisLawrence F Eichenfield, Anne W Lucky, Mark Boguniewicz, et al.
Pageof 16

Showing results (41-50 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Investigative Dermatology|August 12, 2004
Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatologyMary M Prendergast, William Abramovits, Mark Boguniewicz, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 2, 2026
Atopic dermatitis Yardstick: a new era of topical and systemic treatmentsAnna De Benedetto, Mark Boguniewicz, Luz Fonacier, et al.
The Journal of Allergy and Clinical Immunology|August 23, 2024
Dupilumab reduces inflammatory biomarkers in pediatric patients with moderate-to-severe atopic dermatitisLisa A Beck, Antonella Muraro, Mark Boguniewicz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 9, 2024
Atopic Dermatitis (Eczema) Guidelines 2023: HighlightsAnna De Benedetto, Mark Boguniewicz, Peck Y Ong, et al.
The Journal of Clinical Investigation|March 3, 2004
New insights into atopic dermatitisDonald Y M Leung, Mark Boguniewicz, Michael D Howell, et al.
The Journal of Allergy and Clinical Immunology|June 10, 2008
Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3Kevin O Kisich, Charles W Carspecken, Stephanie Fiéve, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 24, 2017
Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscapeMark Boguniewicz, Luz Fonacier, Emma Guttman-Yassky, et al.
The Journal of Allergy and Clinical Immunology|December 6, 2003
Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysisIchiro Nomura, Bifeng Gao, Mark Boguniewicz, et al.
Pediatric Dermatology|June 26, 2008
Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitisRichard G B Langley, Lawrence F Eichenfield, Anne W Lucky, et al.
Archives of Dermatology|October 22, 2003
1% pimecrolimus cream for atopic dermatitisLawrence F Eichenfield, Anne W Lucky, Mark Boguniewicz, et al.
Pageof 16